dc.date.accessioned2022-06-25T20:36:41Z
dc.date.available2022-06-25T20:36:41Z
dc.date.created2022-06-25T20:36:41Z
dc.date.issued2022
dc.identifierhttps://hdl.handle.net/20.500.12866/11849
dc.identifierhttps://doi.org/10.17235/reed.2021.8318/2021
dc.description.abstractDifferent substances are used for submucosal injection in order to perform a safe endoscopic mucosal resection. Viscous solutions such as sodium hyaluronate are currently considered as the first line substances for submucosal injection. This product produces a durable lifting of the mucosa. However, this solution is expensive and only available in Japan. We report on the use of off-label 0.4 % sodium hyaluronate teardrops as a substance for submucosal injection...
dc.languageeng
dc.publisherARAN Ediciones
dc.relationRevista Espanola de Enfermedades Digestivas
dc.relation1130-0108
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectSodium hyaluronate
dc.subjectCarcinoid tumor
dc.subjectEMR-band ligation
dc.titleOff-label use of 0.4 % sodium hyaluronate teardrops for endoscopic resection of a rectal carcinoid
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución